This NGS-based technology identifies mutational variants of the epidermal growth factor receptor (EGFR) in ct-DNA originated from metastatic non-small-cell lung cancer (NSCLC) [138]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.